about
Limitations and difficulties of echocardiographic short-axis assessment of paravalvular leakage after corevalve transcatheter aortic valve implantation.Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review.Prediction of paravalvular leakage after transcatheter aortic valve implantation.Dobutamine stress MRI versus threedimensional contrast echocardiography: It's all Black and WhiteNo relationship between left ventricular radial wall motion and longitudinal velocity and the extent and severity of noncompaction cardiomyopathy.Role of parasternal data acquisition during contrast enhanced real-time three-dimensional echocardiography.Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.Value of assessment of tricuspid annulus: real-time three-dimensional echocardiography and magnetic resonance imaging.Alterations in aortic elasticity in noncompaction cardiomyopathy.An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography.Evaluation of left atrial systolic function in noncompaction cardiomyopathy by real-time three-dimensional echocardiographyEchocardiographic evaluation and clinical implications of aortic stiffness and coronary flow reserve and their relation.Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography.Contrast echocardiography: mechanism of action, safety and clinical applications.Transcatheter aortic valve update 2013.New Scores for the Assessment of Mitral Stenosis Using Real-Time Three-Dimensional Echocardiography.Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy.Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.Diagnostic uncertainties and future perspectives in noncompaction cardiomyopathy.Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility.Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study.Left ventricular remodelling and systolic function measurement with 64 multi-slice computed tomography versus second harmonic echocardiography in patients with coronary artery disease: a double blind study.Automated in-line mixing system for large scale production of chitosan-based polyplexes.Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry.Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II.A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI.Test-retest variability of volumetric right ventricular measurements using real-time three-dimensional echocardiography.Contributions of simultaneous multiplane echocardiographic imaging in daily clinical practice.Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.Regional left ventricular rotation and back-rotation in patients with reverse septal curvature hypertrophic cardiomyopathy.Single-beat real-time three-dimensional echocardiographic automated contour detection for quantification of left ventricular volumes and systolic function.Cardiac involvement in adults with Pompe disease.Assessment of pulmonary valve and right ventricular outflow tract with real-time three-dimensional echocardiography.Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock.Restorative valve therapy by endogenous tissue restoration: tomorrow's world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration.Midterm performance of a novel restorative pulmonary valved conduit: preclinical results.Assessment of mitral annulus size and function by real-time 3-dimensional echocardiography in cardiomyopathy: comparison with magnetic resonance imaging.A simplified and reproducible method to size the mitral annulus: implications for transcatheter mitral valve replacement.
P50
Q28075918-AE94B2D6-1BD3-4CEB-917A-705A6355CC75Q30365700-8EA581B8-313E-43DB-A52B-31B6C2FB1718Q30402553-DA1750F3-59B7-49FF-97B4-7055602A5A26Q30493857-024CC80D-67FB-44AB-BB5B-BC70CAA57970Q30513997-D5C4C574-E4A8-443F-8ECE-1E7C0A0FE32AQ31136206-0D903072-F482-46D1-9083-51B22CCEA3F4Q33557512-B9DC182D-C478-41B5-9506-FFBFE5E8868FQ36103124-21083A9A-056B-428B-AAAC-F7D539C8758DQ36237812-20E50015-2E41-40A3-B73F-5C4912119041Q36237816-B87679DD-6703-46F0-AD6C-54B6E53BD1DEQ36444807-C6BB6E5C-CBB1-49D4-9207-5D4ED363146DQ36980466-40456403-8800-4056-A81C-CF922314F92EQ37600268-AEEE215B-1C28-4406-A19E-193F6A5E7735Q37756502-C55638DB-1CC1-4E27-922B-8839E14EEB77Q38136470-A9D9835E-0545-4CF4-9AC0-C73D1222138CQ38281532-E57CC7FE-F594-427C-B773-6681A93A54A7Q38807773-9F201C8A-EE63-4B64-B717-86A7C2D4980EQ38849397-9CC366E7-0878-463F-ADB1-59A089067914Q39195668-6E1D4F63-A378-41F5-AB42-87B1395BC056Q39320645-C785FF5C-605C-4945-9A97-2954F5B5A914Q39453560-8A1284AA-0298-48C7-9605-885E40F1C570Q39735849-E2C17A61-5E9A-48F0-B43C-C721CE6000A5Q39943860-9EF4EC9D-9F3A-4336-8692-5F4712578D75Q40027402-7D1E8FB9-0613-457E-ABFE-D704D458021AQ40241662-27A9C612-6690-4CC5-AB26-0BF8DEEFEF3FQ40841142-BF8A2BF6-EA94-4BF3-B91A-50186D6A46D7Q40862992-666D3A19-EC0B-493F-A11E-6646F953C6BFQ41082032-F02C6416-CAA9-4FBD-8164-B0AEF74641E6Q43533460-7503CD5C-D860-4165-B8CE-8C0B3078C169Q43851186-FA65DCDF-44D4-4D11-8D16-CFDD3613E837Q43956436-62222EF4-82E7-497C-8EAF-B2528A103FF7Q44527288-5534F1FA-985B-42F7-86FD-E8FBF24EF981Q46065144-E4AA9A84-AA78-4494-A551-1F0F6C749F12Q46657526-00312BB4-4A23-405C-8122-B1A61E18C821Q46889654-8876BA83-AD84-4505-A21E-7B6E3F29F1BEQ47162974-CA6BBD78-AF0E-4BE6-9D01-FABBB5B8F626Q47191731-5A9EBD62-7F9C-47B2-BA14-DD441CD19C4FQ47260877-1B81D79E-815F-4E22-ACC3-1E02E9D212BBQ47284699-08E14741-8AFE-46CA-B1DC-D3E4F242688EQ47293172-ACB4B895-C81A-4316-B217-FDF89B4C373F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Osama Soliman
@ast
Osama Soliman
@en
Osama Soliman
@es
Osama Soliman
@nl
type
label
Osama Soliman
@ast
Osama Soliman
@en
Osama Soliman
@es
Osama Soliman
@nl
prefLabel
Osama Soliman
@ast
Osama Soliman
@en
Osama Soliman
@es
Osama Soliman
@nl
P106
P1153
15046011300
P31
P496
0000-0003-0758-3539